Skip to main navigation Skip to search Skip to main content

Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemia

  • Amgen Incorporated

Research output: Contribution to journal › Meeting Abstract

Fingerprint

Dive into the research topics of 'Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemia'. Together they form a unique fingerprint.
Sort by

Neuroscience

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science